Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
galectin therapeutics和其他2只股票低于$5，内部人员正在购买
The Dow Jones index closed lower by over 50 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周二收跌50多点。内部人士购买或出售股票时，表明他们对公司前景的信心或关注。有兴趣购买便士股票的投资者和交易员可以考虑这一因素，作为他们整体投资或交易决策的因素之一。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是几个近期关于低价股的值得关注的内部交易。了解更多，请查看Benzinga内幕交易平台。
Bespoke Extracts
Bespoke Extracts
- The Trade: Bespoke Extracts, Inc. (OTC:BSPK) CEO Michael Feinsod bought a total of 3,000 shares at an average price of $0.07. To acquire these shares, it cost around $210.
- What's Happening: The company's stock jumped around 51% over the past six months.
- What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.
- 交易：Bespoke Extracts公司（OTC：BSPK）的CEO Michael Feinsod以平均价格0.07美元购买了总计3,000股股票。购买这些股票需要花费约210美元。
- 近六个月以来，该公司的股票上涨了大约51％。
- Bespoke Extracts Inc专注于销售其专有系列的特制、优质、大麻衍生的CBD产品。
Galectin Therapeutics
Galectin Therapeutics
- The Trade: Galectin Therapeutics Inc. (NASDAQ:GALT) Director Kary Eldred acquired a total of 400 shares at an average price of $2.39. To acquire these shares, it cost around $956.00.
- What's Happening: On May 15, Galectin Therapeutics posted a wider-than-expected quarterly loss.
- What Galectin Therapeutics Does: Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company.
- 交易：Galectin Therapeutics公司（NASDAQ：GALT）的董事Kary Eldred以平均价格2.39美元购买了总计400股股票。购买这些股票需要花费约956.00美元。
- 5月15日，Galectin Therapeutics发布了超出预期的季度亏损。
- Galectin Therapeutics Inc是一家临床阶段生物制药公司。
RENN Fund
renn fund
- The Trade: RENN Fund, Inc. (NYSE:RCG) President and CEO Murray Stahl acquired a total of 1,499 shares at an average price of $1.81. The insider spent around $2,713 to buy those shares.
- What's Happening: RENN Fund shares rose around 7% over the past month.
- What RENN Fund Does: RENN Fund Inc is active in the financial services domain.
- 交易：RENN基金公司（NYSE：RCG）的总裁兼首席执行官Murray Stahl以平均价格1.81美元购买了总共1,499股股票。这位内部人士花费约2,713美元购买了这些股票。
- 近一个月来，RENN Fund股票上涨了约7％。
- RENN Fund Inc在金融服务领域活跃。
- Best Buy, Kroger And 2 Other Stocks Insiders Are Selling
- 百思买、Kroger和其他2只股票的内部人士正在出售